MARKET

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ
0.2599
+0.0260
+11.12%
After Hours: 0.2500 -0.0099 -3.81% 19:59 02/06 EST
OPEN
0.2300
PREV CLOSE
0.2339
HIGH
0.2599
LOW
0.2223
VOLUME
8.49M
TURNOVER
--
52 WEEK HIGH
2.310
52 WEEK LOW
0.1634
MARKET CAP
46.36M
P/E (TTM)
-0.1522
1D
5D
1M
3M
1Y
5Y
1D
Plus Therapeutics (PSTV) Gets a Buy from Lake Street
TipRanks · 2d ago
Plus Therapeutics initiated with a Buy at Lake Street
TipRanks · 4d ago
Weekly Report: what happened at PSTV last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at PSTV last week (0119-0123)?
Weekly Report · 01/26 09:01
Plus Therapeutics price target lowered to $1.50 from $3 at Maxim
TipRanks · 01/23 15:00
Maxim Group Sticks to Their Buy Rating for Plus Therapeutics (PSTV)
TipRanks · 01/23 14:36
Plus Therapeutics Price Target Cut to $1.00/Share From $2.00 by HC Wainwright & Co.
Dow Jones · 01/23 11:38
Plus Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 01/23 11:38
More
About PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system. Combining image-guided local beta radiation and targeted drug delivery approaches, it is advancing a pipeline of product candidates with lead programs in leptomeningeal metastases (LM) and recurrent glioblastoma (GBM). Its lead radiotherapeutic candidate, REYOBIQ (rhenium (186Re) obisbemeda), is designed specifically for CNS cancers including GBM, LM, and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. Its radiotherapeutic candidate, Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere (188RNL-BAM), is designed to treat many solid organ cancers including primary and secondary liver cancers via intra-arterial injections.

Webull offers Plus Therapeutics Inc (USA) stock information, including NASDAQ: PSTV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PSTV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PSTV stock methods without spending real money on the virtual paper trading platform.